TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

Researchers say pharmacological attenuation of CDC42, a protein coding gene, effectively addresses bone-related problems caused by cytotoxic conditioning required before hematopoietic stem cell...

For patients undergoing hematopoietic cell transplantation (HCT) from a 10/10 HLA-matched unrelated donor, scientists agree that the age of the donor matters more than T-cell epitope DP-matching.

Haploidentical donors are becoming more common for hematopoietic cell transplantations (HCT) in patients with myelofibrosis.

Researchers say high-risk allogeneic hematopoietic cell transplantation (HCT) recipients approaching their procedure date should be monitored for cytomegalovirus (CMV) reactivation, which predicts...

Advancements in medical research are constantly transforming oncology care, bringing new hopes to patients, and posing fresh challenges for clinicians.

Although research suggests more non-White patients are undergoing and surviving hematopoietic cell transplantation (HCT), outcome disparities persist.